Swandal Craig A. 5
5 · Apyx Medical Corp · Filed Feb 12, 2021
Insider Transaction Report
Form 5
Swandal Craig A.
Director
Transactions
- Exercise/Conversion
Common Stock
2020-03-04$7.28/sh+9,916$72,188→ 17,000 total - Exercise/Conversion
Common Stock
2020-10-07$7.28/sh+7,084$51,572→ 17,000 total - Exercise/Conversion
Stock Option (Option to Buy)
2020-03-04$7.28/sh−9,916$72,188→ 0 totalExercise: $7.28From: 2020-08-01Exp: 2029-08-01→ Common Stock (9,916 underlying) - Exercise/Conversion
Stock Option (Option to Buy)
2020-10-07$7.28/sh−7,084$51,572→ 0 totalExercise: $7.28From: 2020-08-01Exp: 2029-08-01→ Common Stock (7,084 underlying)
Footnotes (1)
- [F1]The transactions reported reflect the exercise of stock options.